Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 24

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 24
---
, or the BVI, which in turns holds all the issued Shares of Living Homeopathy Hong Kong, our operating subsidiary in Hong Kong. Cash is transferred through our organization in the following manner: (i) provided such funding is in the best interests of the Living Homeopathy, funds may be transferred from Living Homeopathy, the holding company incorporated in the Cayman Islands to Living Homeopathy Hong Kong through our BVI intermediary holding company in the form of capital contributions or shareholder loans, as the case may be; and (ii) dividends or other distributions may be paid by Living Homeopathy Hong Kong to Living Homeopathy though our BVI intermediary holding company. Living Homeopathy Hong Kong is permitted under the laws of Hong Kong to provide funding to Living Homeopathy through dividend distribution out of profits available for distribution subject to the Companies Ordinance (Cap. 622, Laws of Hong Kong) and its memorandum and articles of association without restrictions on the amount of the funds or restrictions on foreign exchange. If Living Homeopathy intends to distribute dividends to its shareholders, it will depend on payment of dividends from Living Homeopathy Hong Kong to Living Homeopathy in accordance with the laws and regulations of Hong Kong, and the dividends will be distributed by Living Homeopathy, subject to applicable Cayman Islands restrictions (see “Dividend Policy” on page 51 of this prospectus), to all shareholders respectively in proportion to the shares they hold, regardless of whether the shareholders are U.S. investors or investors in other countries or regions. If Living Homeopathy incurs debt on its own in the future, the instruments governing such debt may restrict Living Homeopathy’s ability to pay dividends, make distribution or transfer funds to Living Homeopathy. Subject to the Company’s Act and our Amended and Restated Memorandum and Articles of Association, Living Homeopathy’s board of directors may authorize and declare a dividend to shareholders at such time and of such an amount as they think fit if they are satisfied, on reasonable grounds, that immediately following the dividend the value of Living Homeopathy’s assets will exceed its liabilities and Living Homeopathy will be able to pay its debts as they become due.

The Company declared cash dividends of $325,078
and $1,503,204 during the years ended March 31, 2024 and 2023. As of the date of this prospectus, Living Homeopathy does not have any
U.S. investors, so no dividends or distributions have been made to any U.S. investors. Both Living Homeopathy and Living Homeopathy Hong